Cargando…

Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: Current Status and Future Prospects

Visceral leishmaniasis (VL) is a vector-borne chronic infectious disease caused by the protozoan parasite Leishmania donovani or Leishmania infantum. VL is a serious public health problem, causing high morbidity and mortality in the developing world with an estimated 0.2–0.4 million new cases each y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Om Prakash, Sundar, Shyam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135235/ https://www.ncbi.nlm.nih.gov/pubmed/25183962 http://dx.doi.org/10.3389/fimmu.2014.00296

Ejemplares similares

Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era
por: Singh, Om Prakash, et al.
Publicado: (2015)

Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective
por: Singh, Om Prakash, et al.
Publicado: (2016)

Xenodiagnosis to address key questions in visceral leishmaniasis control and elimination
por: Singh, Om Prakash, et al.
Publicado: (2020)

Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)

Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease
por: Roatt, Bruno Mendes, et al.
Publicado: (2014)

Immunotherapy and immunochemotherapy in combating visceral leishmaniasis
por: Yadagiri, Ganesh, et al.
Publicado: (2023)

Cytokine Responses to Novel Antigens in an Indian Population Living in an Area Endemic for Visceral Leishmaniasis
por: Singh, Om Prakash, et al.
Publicado: (2012)

Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects
por: Liu, Zhuoyan, et al.
Publicado: (2021)

Visceral Leishmaniasis in the Muzaffapur Demographic Surveillance Site: A Spatiotemporal Analysis
por: Hasker, Epco, et al.
Publicado: (2018)

Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India
por: Fakiola, Michaela, et al.
Publicado: (2019)

Strong Association between Serological Status and Probability of Progression to Clinical Visceral Leishmaniasis in Prospective Cohort Studies in India and Nepal
por: Hasker, Epco, et al.
Publicado: (2014)

Visceral Leishmaniasis in Rural Bihar, India
por: Hasker, Epco, et al.
Publicado: (2012)

Diagnosis of Visceral Leishmaniasis in an Elimination Setting: A Validation Study of the Diagnostic Algorithm in India
por: Cloots, Kristien, et al.
Publicado: (2022)

Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2017)

Immunobiology of visceral leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2012)

Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis
por: Parvez, Shabi, et al.
Publicado: (2020)

Visceral Leishmaniasis in Bolivia: Current Status
por: Mollinedo, Juan Sergio, et al.
Publicado: (2020)

Leishmania Specific CD4 T Cells Release IFNγ That Limits Parasite Replication in Patients with Visceral Leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2014)

Genetics, Transcriptomics and Meta-Taxonomics in Visceral Leishmaniasis
por: Blackwell, Jenefer M., et al.
Publicado: (2020)

An Insight Into Systemic Immune Response in Leishmania donovani Mediated Atypical Cutaneous Leishmaniasis in the New Endemic State of Himachal Pradesh, India
por: Thakur, Lovlesh, et al.
Publicado: (2022)

Visceral Leishmaniasis in Muzaffarpur District, Bihar, India from 1990 to 2008
por: Malaviya, Paritosh, et al.
Publicado: (2011)

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis
por: Faleiro, Rebecca J., et al.
Publicado: (2016)

Visceral leishmaniasis in eastern Africa – current status
por: Reithinger, Richard, et al.
Publicado: (2007)

Current Status and Future Directions of Bacteria-Based Immunotherapy
por: Tang, Quan, et al.
Publicado: (2022)

Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy
por: Dayakar, Alti, et al.
Publicado: (2019)

Visceral leishmaniasis: Spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India
por: Bulstra, Caroline A., et al.
Publicado: (2018)

Significantly Lower Anti-Leishmania IgG Responses in Sudanese versus Indian Visceral Leishmaniasis
por: Bhattacharyya, Tapan, et al.
Publicado: (2014)

Genetically Modified Organisms and Visceral Leishmaniasis
por: Chhajer, Rudra, et al.
Publicado: (2014)

Detection of Immunoglobulin G1 Against rK39 Improves Monitoring of Treatment Outcomes in Visceral Leishmaniasis
por: Mollett, Guy, et al.
Publicado: (2019)

Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients
por: Adriaensen, Wim, et al.
Publicado: (2018)

Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions
por: Mao, Lili, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent
por: Meheus, Filip, et al.
Publicado: (2010)

Risk Factors for Visceral Leishmaniasis and Asymptomatic Leishmania donovani Infection in India and Nepal
por: Picado, Albert, et al.
Publicado: (2014)

A Vaccine Therapy for Canine Visceral Leishmaniasis Promoted Significant Improvement of Clinical and Immune Status with Reduction in Parasite Burden
por: Roatt, Bruno Mendes, et al.
Publicado: (2017)

Isolation and characterisation of Leishmania donovani protein antigens from urine of visceral leishmaniasis patients
por: Marlais, Tegwen, et al.
Publicado: (2020)

Eliminating visceral leishmaniasis in South Asia: the road ahead
por: Rijal, Suman, et al.
Publicado: (2019)

Immunotherapy for B-Cell Lymphoma: Current Status and Prospective Advances
por: Hollander, Nurit
Publicado: (2012)

Wuchereria bancrofti infection is associated with progression to clinical visceral leishmaniasis in VL- endemic areas in Muzaffarpur, Bihar, India
por: Singh, Abhishek Kumar, et al.
Publicado: (2023)

Laboratory Diagnosis of Cutaneous and Visceral Leishmaniasis: Current and Future Methods
por: Reimão, Juliana Quero, et al.
Publicado: (2020)

Quantitative PCR in Epidemiology for Early Detection of Visceral Leishmaniasis Cases in India
por: Sudarshan, Medhavi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5ibk6ffdhktf02emhu3nu0sscd